Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer

Background: This study compares the surgical and long-term outcomes, including disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS), between lobe-specific lymph node dissection (L-SND) and systematic lymph node dissection (SND) among patients with stage I non-small...

Full description

Bibliographic Details
Main Authors: Ching-Chun Huang, En-Kuei Tang, Chih-Wen Shu, Yi-Ping Chou, Yih-Gang Goan, Yen-Chiang Tseng
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/8/1399
_version_ 1797605763664838656
author Ching-Chun Huang
En-Kuei Tang
Chih-Wen Shu
Yi-Ping Chou
Yih-Gang Goan
Yen-Chiang Tseng
author_facet Ching-Chun Huang
En-Kuei Tang
Chih-Wen Shu
Yi-Ping Chou
Yih-Gang Goan
Yen-Chiang Tseng
author_sort Ching-Chun Huang
collection DOAJ
description Background: This study compares the surgical and long-term outcomes, including disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS), between lobe-specific lymph node dissection (L-SND) and systematic lymph node dissection (SND) among patients with stage I non-small cell lung cancer (NSCLC).Methods: In this retrospective study, 107 patients diagnosed with clinical stage I NSCLC undergoing video-assisted thoracic surgery lobectomy (exclusion of the right middle lobe) from January 2011 to December 2018 were enrolled. The patients were assigned to the L-SND (<i>n</i> = 28) and SND (<i>n</i> = 79) groups according to the procedure performed on them. Demographics, perioperative data, and surgical and long-term oncological outcomes were collected and compared between the L-SND and SND groups. Results: The mean follow-duration was 60.6 months. The demographic data and surgical outcomes and long-term oncological outcomes were not significantly different between the two groups. The 5-year OS of the L-SND and SND groups was 82% and 84%, respectively. The 5-year DFS of the L-SND and SND groups was 70% and 65%, respectively. The 5-year CSS of the L-SND and SND groups was 80% and 86%, respectively. All the surgical and long-term outcomes were not statistically different between the two groups. Conclusion: L-SND showed comparable surgical and oncologic outcomes with SND for clinical stage I NSCLC. L-SND could be a treatment choice for stage I NSCLC.
first_indexed 2024-03-11T05:05:41Z
format Article
id doaj.art-181c7c46627c4aaaae5a9d5daae71b8b
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T05:05:41Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-181c7c46627c4aaaae5a9d5daae71b8b2023-11-17T18:54:33ZengMDPI AGDiagnostics2075-44182023-04-01138139910.3390/diagnostics13081399Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung CancerChing-Chun Huang0En-Kuei Tang1Chih-Wen Shu2Yi-Ping Chou3Yih-Gang Goan4Yen-Chiang Tseng5Division of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanDivision of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanInstitute of BioPharmaceutical Sciences, National Sun Yat-Sen University, Kaohsiung 804, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei 112, TaiwanDivision of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanDivision of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, TaiwanBackground: This study compares the surgical and long-term outcomes, including disease-free survival (DFS), overall survival (OS), and cancer-specific survival (CSS), between lobe-specific lymph node dissection (L-SND) and systematic lymph node dissection (SND) among patients with stage I non-small cell lung cancer (NSCLC).Methods: In this retrospective study, 107 patients diagnosed with clinical stage I NSCLC undergoing video-assisted thoracic surgery lobectomy (exclusion of the right middle lobe) from January 2011 to December 2018 were enrolled. The patients were assigned to the L-SND (<i>n</i> = 28) and SND (<i>n</i> = 79) groups according to the procedure performed on them. Demographics, perioperative data, and surgical and long-term oncological outcomes were collected and compared between the L-SND and SND groups. Results: The mean follow-duration was 60.6 months. The demographic data and surgical outcomes and long-term oncological outcomes were not significantly different between the two groups. The 5-year OS of the L-SND and SND groups was 82% and 84%, respectively. The 5-year DFS of the L-SND and SND groups was 70% and 65%, respectively. The 5-year CSS of the L-SND and SND groups was 80% and 86%, respectively. All the surgical and long-term outcomes were not statistically different between the two groups. Conclusion: L-SND showed comparable surgical and oncologic outcomes with SND for clinical stage I NSCLC. L-SND could be a treatment choice for stage I NSCLC.https://www.mdpi.com/2075-4418/13/8/1399L-SNDNSCLC
spellingShingle Ching-Chun Huang
En-Kuei Tang
Chih-Wen Shu
Yi-Ping Chou
Yih-Gang Goan
Yen-Chiang Tseng
Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
Diagnostics
L-SND
NSCLC
title Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
title_full Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
title_fullStr Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
title_full_unstemmed Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
title_short Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
title_sort comparison of the outcomes between systematic lymph node dissection and lobe specific lymph node dissection for stage i non small cell lung cancer
topic L-SND
NSCLC
url https://www.mdpi.com/2075-4418/13/8/1399
work_keys_str_mv AT chingchunhuang comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer
AT enkueitang comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer
AT chihwenshu comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer
AT yipingchou comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer
AT yihganggoan comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer
AT yenchiangtseng comparisonoftheoutcomesbetweensystematiclymphnodedissectionandlobespecificlymphnodedissectionforstageinonsmallcelllungcancer